XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (9466)	3/31/1999 10:00:00 AM
From: aknahow	Read Replies (2) of 17367

Bob, who was the XOMA patent assigned to? Does the patent now mean XOMA must pay a fee to Dr. Giroir when BPI is used to treat Meningococcemia? Yes I saw that one of the inventors was Dr. Scannon. BTW I always acknowledged that Dr. Giroir was the person responsible for getting XOMA to consider using Neuprex for this indication. My questions are made only to better understand what we may need to know. Bob you may agree with the second dog on this but it may pay to remind yourself that you were convinced that IYO it was not a P II trial. You were correct. <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next